The Myelin Repair Foundation (MRF) today has granted a non-exclusive sublicense to Biogen Idec (NASDAQ: BIIB) for the use of MRF's technologies to generate a novel mouse model for all demyelinating ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the fatty sheath that covers nerve cells in the brain and spinal cord. Chronic ...

A hormone released during pregnancy could help reverse damage in the cortex of the brain caused by multiple sclerosis (MS), a recent study led by UCLA has found. In people with MS, a potentially ...

In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged. This slows the transmission of ...

Ten years of work, and a little help from the green mamba snake, has resulted in a promising new drug that is already being tested in clinical trials. Multiple sclerosis (MS) degrades the protective ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...

In multiple sclerosis (MS), macrophages and microglia play a dual role that could be used to treat this neurodegenerative disease. These cells promote inflammation that demyelinates neurons but also ...

Recent stem cell research could lead to a new way of treating inflammatory diseases, such as multiple sclerosis. New research into inflammatory diseases may have identified a way to treat MS. Multiple ...

Effective targeted treatment of multiple sclerosis (MS) and even the repair of damaged nerves caused by the disease could soon be within grasp, thanks to yet another breakthrough in the field of small ...

An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears ...